Literature DB >> 18387323

Number of microvesicles in peripheral blood and ability of plasma to induce adhesion between phospholipid membranes in 19 patients with gastrointestinal diseases.

Rado Jansa1, Vid Sustar, Mojca Frank, Petra Susanj, Janez Bester, Mateja Mancek-Keber, Mojca Krzan, Ales Iglic.   

Abstract

It was recently shown that the plasma protein-mediated attractive interaction between phospholipid membranes could in the budding process cause adhesion of the bud to the mother membrane [J. Urbanija, N. Tomsic, M. Lokar, A. Ambrozic, S. Cucnik, M. Kanduser, B. Rozman, A. Iglic, V. Kralj-Iglic, Coalescence of phospholipid membranes as a possible origin of anticoagulant effect of serum proteins, Chem. Phys. Lipids 150 (2007) 49-57]. Since in the in vivo conditions the budding of cell membranes leads to the release of microvesicles into the circulation, a hypothesis was put forward that the ability of plasma to cause adhesion between membranes supresses the microvesiculation process. In the present work, this hypothesis was tested in a population of 19 patients with gastrointestinal diseases. The number of microvesicles in peripheral blood of patients was determined by flow cytometry while the ability of plasma to cause adhesion between membranes was determined by adding patient's plasma to the suspension of giant phospholipid vesicles created by electroformation method, and measuring the average effective angle of contact between the adhered vesicles. Statistically significant negative correlations between the number of microvesicles and the average effective angle of contact (Pearson coefficient -0.50, p=0.031) and between the number of microvesicles per number of platelets and the average effective angle of contact (Pearson coefficient -0.64, p=0.003) were found, which is in favor of the above hypothesis. Patients with gastrointestinal cancer had larger number of microvesicles (difference 140%, statistical significance 0.033) and smaller average effective angle of contact (difference 20%, statistical significance 0.013) compared to patients with other gastrointestinal diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18387323     DOI: 10.1016/j.bcmd.2008.01.009

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  9 in total

Review 1.  CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

Authors:  Ming-Chung Jiang
Journal:  Tumour Biol       Date:  2016-09-05

2.  Functional role of microvesicles in gastrointestinal malignancies.

Authors:  Kelly McDaniel; Robert Correa; Tianhao Zhou; Christopher Johnson; Heather Francis; Shannon Glaser; Julie Venter; Gianfranco Alpini; Fanyin Meng
Journal:  Ann Transl Med       Date:  2013-04-01

3.  Nanoparticles isolated from blood: a reflection of vesiculability of blood cells during the isolation process.

Authors:  Vid Suštar; Apolonija Bedina-Zavec; Roman Stukelj; Mojca Frank; Goran Bobojević; Rado Janša; Eva Ogorevc; Peter Kruljc; Keriya Mam; Boštjan Simunič; Mateja Manček-Keber; Roman Jerala; Blaž Rozman; Peter Veranič; Henry Hägerstrand; Veronika Kralj-Iglič
Journal:  Int J Nanomedicine       Date:  2011-11-08

4.  Determination of the strength of adhesion between lipid vesicles.

Authors:  Tomáš Mareš; Matej Daniel; Aleš Iglič; Veronika Kralj-Iglič; Miha Fošnarič
Journal:  ScientificWorldJournal       Date:  2012-01-04

Review 5.  Glioblastoma extracellular vesicles: reservoirs of potential biomarkers.

Authors:  Jasmina S Redzic; Timothy H Ung; Michael W Graner
Journal:  Pharmgenomics Pers Med       Date:  2014-02-13

6.  Stability of membranous nanostructures: a possible key mechanism in cancer progression.

Authors:  Veronika Kralj-Iglic
Journal:  Int J Nanomedicine       Date:  2012-07-12

7.  Effect of engineered TiO2 and ZnO nanoparticles on erythrocytes, platelet-rich plasma and giant unilamelar phospholipid vesicles.

Authors:  Metka Šimundić; Barbara Drašler; Vid Šuštar; Jernej Zupanc; Roman Štukelj; Darko Makovec; Deniz Erdogmus; Henry Hägerstrand; Damjana Drobne; Veronika Kralj-Iglič
Journal:  BMC Vet Res       Date:  2013-01-11       Impact factor: 2.741

Review 8.  The role of extracellular vesicles in phenotypic cancer transformation.

Authors:  Eva Ogorevc; Veronika Kralj-Iglic; Peter Veranic
Journal:  Radiol Oncol       Date:  2013-07-30       Impact factor: 2.991

Review 9.  Mechanisms for the formation of membranous nanostructures in cell-to-cell communication.

Authors:  Karin Schara; Vid Jansa; Vid Sustar; Drago Dolinar; Janez Ivan Pavlic; Marusa Lokar; Veronika Kralj-Iglic; Peter Veranic; Ales Iglic
Journal:  Cell Mol Biol Lett       Date:  2009-06-25       Impact factor: 5.787

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.